Stress, neuropeptides and gastric mucosa

Klara Gyires, Ágnes Fehér

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Exposure of the organism to a hostile stimulus results in a series of coordinated reactions that aim to avoid the aversive effect and maintain or restore homeostasis of the organism. In response to noxious stimuli corticotropin-releasing factor (CRF), the primary mediator of stress responses is released from the paraventricular nucleus resulting in activation of the hypothalamic-pituitary-adrenocortical axis and coordination of the endocrine, autonomic, behavioral and immune responses to stress. Several other neuropeptides, released in a coordinated way are also involved in the regulation of the stress response. However, besides the development of adaptive physiological, beneficial reactions, pathological, non-desired somatic and psychic responses can also develop, among others: gastric mucosal damage, erosion and ulceration. The mechanism of stress-related gastric mucosal injury is not fully understood; both mucosal injurious and protective mechanisms are activated in response to stress. Decreased mucosal circulation due to redistribution of blood flow from the visceral region toward the vital organs seems to be the primary mechanism of gastric mucosal damage. Mucosal hypoperfusion can result in mucosal ischemia, free radical formation and gastric hypomotiliy. On the other hand, several stressrelated neuropeptides, such as CRF, SP, N/OFQ, opioids, oxytocin and prolactin have been reported to inhibit the stress- and other ulcerogenic stimulus-induced mucosal lesions independently on their effect on other stressrelated symptoms. Consequently, neuropeptides released during stress, besides their numerous physiological and pathophysiological functions, may initiate adaptive mechanisms as well as counteract the stress-induced gastric mucosal injury.

Original languageEnglish
Pages (from-to)3928-3940
Number of pages13
JournalCurrent Pharmaceutical Design
Volume23
Issue number27
DOIs
Publication statusPublished - Aug 1 2017

Fingerprint

Gastric Mucosa
Neuropeptides
Stomach
Corticotropin-Releasing Hormone
Paraventricular Hypothalamic Nucleus
Wounds and Injuries
Oxytocin
Prolactin
Opioid Analgesics
Free Radicals
Homeostasis
Ischemia

Keywords

  • Gastric mucosal lesions
  • Hypothalamic-pituitary-adrenocortical axis
  • Mucosal circulation
  • Neuropeptides
  • Stress

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Stress, neuropeptides and gastric mucosa. / Gyires, Klara; Fehér, Ágnes.

In: Current Pharmaceutical Design, Vol. 23, No. 27, 01.08.2017, p. 3928-3940.

Research output: Contribution to journalReview article

Gyires, Klara ; Fehér, Ágnes. / Stress, neuropeptides and gastric mucosa. In: Current Pharmaceutical Design. 2017 ; Vol. 23, No. 27. pp. 3928-3940.
@article{a7893d300dae4482b663262c284ccade,
title = "Stress, neuropeptides and gastric mucosa",
abstract = "Exposure of the organism to a hostile stimulus results in a series of coordinated reactions that aim to avoid the aversive effect and maintain or restore homeostasis of the organism. In response to noxious stimuli corticotropin-releasing factor (CRF), the primary mediator of stress responses is released from the paraventricular nucleus resulting in activation of the hypothalamic-pituitary-adrenocortical axis and coordination of the endocrine, autonomic, behavioral and immune responses to stress. Several other neuropeptides, released in a coordinated way are also involved in the regulation of the stress response. However, besides the development of adaptive physiological, beneficial reactions, pathological, non-desired somatic and psychic responses can also develop, among others: gastric mucosal damage, erosion and ulceration. The mechanism of stress-related gastric mucosal injury is not fully understood; both mucosal injurious and protective mechanisms are activated in response to stress. Decreased mucosal circulation due to redistribution of blood flow from the visceral region toward the vital organs seems to be the primary mechanism of gastric mucosal damage. Mucosal hypoperfusion can result in mucosal ischemia, free radical formation and gastric hypomotiliy. On the other hand, several stressrelated neuropeptides, such as CRF, SP, N/OFQ, opioids, oxytocin and prolactin have been reported to inhibit the stress- and other ulcerogenic stimulus-induced mucosal lesions independently on their effect on other stressrelated symptoms. Consequently, neuropeptides released during stress, besides their numerous physiological and pathophysiological functions, may initiate adaptive mechanisms as well as counteract the stress-induced gastric mucosal injury.",
keywords = "Gastric mucosal lesions, Hypothalamic-pituitary-adrenocortical axis, Mucosal circulation, Neuropeptides, Stress",
author = "Klara Gyires and {\'A}gnes Feh{\'e}r",
year = "2017",
month = "8",
day = "1",
doi = "10.2174/1381612823666161118144216",
language = "English",
volume = "23",
pages = "3928--3940",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "27",

}

TY - JOUR

T1 - Stress, neuropeptides and gastric mucosa

AU - Gyires, Klara

AU - Fehér, Ágnes

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Exposure of the organism to a hostile stimulus results in a series of coordinated reactions that aim to avoid the aversive effect and maintain or restore homeostasis of the organism. In response to noxious stimuli corticotropin-releasing factor (CRF), the primary mediator of stress responses is released from the paraventricular nucleus resulting in activation of the hypothalamic-pituitary-adrenocortical axis and coordination of the endocrine, autonomic, behavioral and immune responses to stress. Several other neuropeptides, released in a coordinated way are also involved in the regulation of the stress response. However, besides the development of adaptive physiological, beneficial reactions, pathological, non-desired somatic and psychic responses can also develop, among others: gastric mucosal damage, erosion and ulceration. The mechanism of stress-related gastric mucosal injury is not fully understood; both mucosal injurious and protective mechanisms are activated in response to stress. Decreased mucosal circulation due to redistribution of blood flow from the visceral region toward the vital organs seems to be the primary mechanism of gastric mucosal damage. Mucosal hypoperfusion can result in mucosal ischemia, free radical formation and gastric hypomotiliy. On the other hand, several stressrelated neuropeptides, such as CRF, SP, N/OFQ, opioids, oxytocin and prolactin have been reported to inhibit the stress- and other ulcerogenic stimulus-induced mucosal lesions independently on their effect on other stressrelated symptoms. Consequently, neuropeptides released during stress, besides their numerous physiological and pathophysiological functions, may initiate adaptive mechanisms as well as counteract the stress-induced gastric mucosal injury.

AB - Exposure of the organism to a hostile stimulus results in a series of coordinated reactions that aim to avoid the aversive effect and maintain or restore homeostasis of the organism. In response to noxious stimuli corticotropin-releasing factor (CRF), the primary mediator of stress responses is released from the paraventricular nucleus resulting in activation of the hypothalamic-pituitary-adrenocortical axis and coordination of the endocrine, autonomic, behavioral and immune responses to stress. Several other neuropeptides, released in a coordinated way are also involved in the regulation of the stress response. However, besides the development of adaptive physiological, beneficial reactions, pathological, non-desired somatic and psychic responses can also develop, among others: gastric mucosal damage, erosion and ulceration. The mechanism of stress-related gastric mucosal injury is not fully understood; both mucosal injurious and protective mechanisms are activated in response to stress. Decreased mucosal circulation due to redistribution of blood flow from the visceral region toward the vital organs seems to be the primary mechanism of gastric mucosal damage. Mucosal hypoperfusion can result in mucosal ischemia, free radical formation and gastric hypomotiliy. On the other hand, several stressrelated neuropeptides, such as CRF, SP, N/OFQ, opioids, oxytocin and prolactin have been reported to inhibit the stress- and other ulcerogenic stimulus-induced mucosal lesions independently on their effect on other stressrelated symptoms. Consequently, neuropeptides released during stress, besides their numerous physiological and pathophysiological functions, may initiate adaptive mechanisms as well as counteract the stress-induced gastric mucosal injury.

KW - Gastric mucosal lesions

KW - Hypothalamic-pituitary-adrenocortical axis

KW - Mucosal circulation

KW - Neuropeptides

KW - Stress

UR - http://www.scopus.com/inward/record.url?scp=85038611818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038611818&partnerID=8YFLogxK

U2 - 10.2174/1381612823666161118144216

DO - 10.2174/1381612823666161118144216

M3 - Review article

C2 - 27855611

AN - SCOPUS:85038611818

VL - 23

SP - 3928

EP - 3940

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 27

ER -